These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19300612)

  • 21. [The newer sedative-hypnotics].
    Sukys-Claudino L; Moraes WA; Tufik S; Poyares D
    Braz J Psychiatry; 2010 Sep; 32(3):288-93. PubMed ID: 20945020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
    Farber RH; Burke PJ
    Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New hypnotics: perspectives from sleep physiology].
    Jufe GS
    Vertex; 2007; 18(74):294-9. PubMed ID: 18265473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New and emerging pharmacotherapeutic approaches for insomnia.
    Neubauer DN
    Int Rev Psychiatry; 2014 Apr; 26(2):214-24. PubMed ID: 24892896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of insomnia in older people.
    McCall WV
    J Am Geriatr Soc; 2005 Jul; 53(7 Suppl):S272-7. PubMed ID: 15982376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marine Polyphenol Phlorotannins as a Natural Sleep Aid for Treatment of Insomnia: A Review of Sedative-Hypnotic Effects and Mechanism of Action.
    Kim S; Kim D; Um MY; Yoon M; Choi JS; Choi YH; Cho S
    Mar Drugs; 2022 Dec; 20(12):. PubMed ID: 36547921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.
    Weitzel KW; Wickman JM; Augustin SG; Strom JG
    Clin Ther; 2000 Nov; 22(11):1254-67. PubMed ID: 11117652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?
    Srinivasan V; Brzezinski A; Pandi-Perumal SR; Spence DW; Cardinali DP; Brown GM
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):913-23. PubMed ID: 21453740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of Sleep Medications via a Combined Digital Insomnia and Pharmacist-Led Deprescribing Intervention: Protocol for a Feasibility Trial.
    Bramoweth AD; Hough CE; McQuillan AD; Spitznogle BL; Thorpe CT; Lickel JJ; Boudreaux-Kelly M; Hamm ME; Germain A
    JMIR Res Protoc; 2023 Jul; 12():e47636. PubMed ID: 37471122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Appropriate Use and Abuse of Sedative-Hypnotic Drugs].
    Zheng JW; Meng SQ; Liu WY; Chang XW; Shi J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):231-239. PubMed ID: 36949678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
    Jhaveri M; Seal B; Pollack M; Wertz D
    Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eszopiclone: its use in the treatment of insomnia.
    Monti JM; Pandi-Perumal SR
    Neuropsychiatr Dis Treat; 2007 Aug; 3(4):441-53. PubMed ID: 19300573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ramelteon: a novel hypnotic indicated for the treatment of insomnia.
    Zammit GK
    Psychiatry (Edgmont); 2007 Sep; 4(9):36-42. PubMed ID: 20532119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.
    Rosenberg RP
    Ann Clin Psychiatry; 2006; 18(1):49-56. PubMed ID: 16517453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indiplon is hydrolyzed by arylacetamide deacetylase in human liver.
    Shimizu M; Fukami T; Ito Y; Kurokawa T; Kariya M; Nakajima M; Yokoi T
    Drug Metab Dispos; 2014 Apr; 42(4):751-8. PubMed ID: 24464802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New perspectives for the treatment of disorders of sleep and arousal.
    Sanger DJ; Soubrane C; Scatton B
    Ann Pharm Fr; 2007 Jul; 65(4):268-74. PubMed ID: 17652996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paradoxical Insomnia in a Frustrated Patient Treated With Hypnotics for Ten Years.
    Wasey W; Saleh S; Abernathy K; Sapra A; Bhandari P
    Cureus; 2021 Jul; 13(7):e16234. PubMed ID: 34367831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro metabolism of indiplon and an assessment of its drug interaction potential.
    Madan A; Fisher A; Jin L; Chapman D; Bozigian HP
    Xenobiotica; 2007 Jul; 37(7):736-52. PubMed ID: 17620220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of Insomnia and Sedative-Hypnotic Drug Use Associated with Frailty Over Time Among Older Adults.
    Wu CS; Tseng HY; Lee CY; Wu IC; Chang HY; Hsu CC; Hsiung CA; Chiu YF
    Am J Geriatr Psychiatry; 2023 Jun; 31(6):438-448. PubMed ID: 36858927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.